Brown JA - Search Results

1

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. Kuchroo VK, et al. Among authors: brown ja. Cell. 1995 Mar 10;80(5):707-18. doi: 10.1016/0092-8674(95)90349-6. Cell. 1995. PMID: 7534215 Free article.

2

Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response.

Brown JA, Titus RG, Nabavi N, Glimcher LH. Brown JA, et al. J Infect Dis. 1996 Dec;174(6):1303-8. doi: 10.1093/infdis/174.6.1303. J Infect Dis. 1996. PMID: 8940222

3

Regulation of the E beta gene in vivo: lessons from E beta d transgenic mice.

Douhan J 3rd, Brown JA, Gleit ZL, David CS, Glimcher LH. Douhan J 3rd, et al. Among authors: brown ja. Int Immunol. 1996 Feb;8(2):255-65. doi: 10.1093/intimm/8.2.255. Int Immunol. 1996. PMID: 8671611

4

T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major.

Brown JA, Greenwald RJ, Scott S, Schweitzer AN, Satoskar AR, Chung C, Schopf LR, van der Woude D, Sypek JP, Sharpe AH. Brown JA, et al. Eur J Immunol. 2002 Jun;32(6):1764-72. doi: 10.1002/1521-4141(200206)32:6<1764::AID-IMMU1764>3.0.CO;2-V. Eur J Immunol. 2002. PMID: 12115660 Free article.

5

CD4+CD25high regulatory cells in human peripheral blood.

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. Baecher-Allan C, et al. Among authors: brown ja. J Immunol. 2001 Aug 1;167(3):1245-53. doi: 10.4049/jimmunol.167.3.1245. J Immunol. 2001. PMID: 11466340

6

PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Latchman Y, et al. Among authors: brown ja. Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527

7

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ. Brown JA, et al. J Immunol. 2003 Feb 1;170(3):1257-66. doi: 10.4049/jimmunol.170.3.1257. J Immunol. 2003. PMID: 12538684

8

CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. Baecher-Allan C, et al. Among authors: brown ja. Novartis Found Symp. 2003;252:67-88; discussion 88-91, 106-14. doi: 10.1002/0470871628.ch6. Novartis Found Symp. 2003. PMID: 14609213

9

CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.

Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. Cai G, et al. Among authors: brown ja. Nat Immunol. 2008 Feb;9(2):176-85. doi: 10.1038/ni1554. Epub 2008 Jan 13. Nat Immunol. 2008. PMID: 18193050

10

CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.

Ge X, Brown J, Sykes M, Boussiotis VA. Ge X, et al. Biol Blood Marrow Transplant. 2008 May;14(5):518-30. doi: 10.1016/j.bbmt.2008.02.010. Biol Blood Marrow Transplant. 2008. PMID: 18410894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,269 results

Search Page

Filters